Profile data is unavailable for this security.
About the company
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
- Revenue in USD (TTM)357.65m
- Net income in USD-545.21m
- Incorporated2006
- Employees879.00
- LocationAscendis Pharma A/STuborg Boulevard 12HELLERUP 2900DenmarkDNK
- Phone+45 70222244
- Websitehttps://ascendispharma.dk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | 218.60m | -538.26m | 5.63bn | 550.00 | -- | -- | -- | 25.76 | -3.23 | -3.23 | 1.29 | -5.61 | 0.2964 | -- | -- | 397,449.10 | -74.13 | -72.44 | -90.19 | -89.72 | 98.91 | 94.41 | -250.09 | -1,225.66 | -- | -11.48 | 2.53 | -- | -88.02 | -- | -33.67 | -- | -40.94 | -- |
| Halozyme Therapeutics, Inc. | 862.99m | 318.80m | 5.69bn | 373.00 | 18.49 | 31.98 | 14.19 | 6.59 | 2.42 | 2.42 | 6.54 | 1.40 | 0.4874 | 1.34 | 4.42 | 2,313,644.00 | 18.01 | 18.22 | 19.22 | 21.97 | 78.50 | 79.05 | 36.94 | 39.36 | 5.36 | 966.62 | 0.8941 | 0.00 | 25.62 | 40.43 | 39.31 | -- | 26.82 | -- |
| Exelixis Inc | 1.85bn | 205.05m | 6.09bn | 1.31k | 32.34 | 2.90 | 26.45 | 3.30 | 0.6466 | 0.6466 | 5.84 | 7.21 | 0.621 | 3.12 | 7.78 | 1,409,653.00 | 6.90 | 8.86 | 7.82 | 9.91 | 95.70 | 96.30 | 11.10 | 15.43 | 3.41 | -- | 0.00 | 0.00 | 13.60 | 16.47 | 13.98 | -21.34 | 3.98 | -- |
| Cytokinetics, Inc. | 3.75m | -530.60m | 6.24bn | 423.00 | -- | -- | -- | 1,663.63 | -5.40 | -5.40 | 0.0382 | -3.78 | 0.0044 | -- | 4.08 | 8,869.98 | -62.50 | -43.14 | -69.19 | -47.22 | -- | -- | -14,141.74 | -540.47 | -- | -15.26 | 2.78 | -- | -92.04 | -24.89 | -35.30 | -- | 9.76 | -- |
| Revolution Medicines Inc | 4.57m | -484.27m | 6.50bn | 411.00 | -- | 3.77 | -- | 1,424.03 | -3.76 | -3.76 | 0.035 | 10.46 | 0.0031 | -- | 2.29 | 12,079.37 | -32.48 | -29.76 | -34.18 | -32.59 | -- | -- | -10,606.04 | -606.93 | -- | -- | 0.00 | -- | -67.27 | -10.50 | -75.46 | -- | 38.82 | -- |
| Blueprint Medicines Corp | 282.21m | -288.29m | 6.57bn | 645.00 | -- | 21.15 | -- | 23.29 | -4.82 | -4.82 | 4.59 | 4.96 | 0.2499 | 0.3531 | 6.18 | 430,853.40 | -25.53 | -29.92 | -30.68 | -34.06 | 96.97 | -- | -102.15 | -116.65 | 3.61 | -23.37 | 0.4352 | -- | 22.22 | 41.14 | 9.06 | -- | 4.85 | -- |
| Intra-Cellular Therapies Inc | 513.93m | -110.87m | 6.86bn | 610.00 | -- | 10.57 | -- | 13.35 | -1.15 | -1.15 | 5.34 | 6.15 | 0.6996 | 1.67 | 4.83 | 842,508.20 | -15.09 | -38.27 | -17.67 | -42.77 | 92.82 | -- | -21.57 | -128.42 | 5.00 | -- | 0.00 | -- | 85.51 | -- | 45.49 | -- | -7.22 | -- |
| Jazz Pharmaceuticals PLC | 3.84bn | 330.79m | 6.87bn | 2.80k | 22.49 | 1.86 | 7.02 | 1.79 | 4.85 | 4.85 | 55.49 | 58.65 | 0.3436 | 0.6428 | 5.78 | 1,372,634.00 | 2.99 | 1.48 | 3.36 | 1.62 | 89.53 | 88.79 | 8.69 | 4.26 | 1.90 | 1.87 | 0.607 | 0.00 | 4.78 | 15.19 | 285.14 | -1.49 | -20.04 | -- |
| Ascendis Pharma A/S (ADR) | 357.65m | -545.21m | 7.05bn | 879.00 | -- | -- | -- | 19.72 | -9.66 | -9.66 | 6.33 | -4.45 | 0.372 | 0.2469 | 11.50 | 406,882.00 | -56.71 | -47.35 | -130.03 | -53.29 | 85.61 | -- | -152.44 | -602.66 | 0.540 | -2.73 | 1.55 | -- | 421.20 | 90.68 | 17.45 | -- | -1.61 | -- |
| Viking Therapeutics Inc | 0.00 | -93.72m | 7.39bn | 28.00 | -- | 7.91 | -- | -- | -0.9305 | -0.9305 | 0.00 | 8.47 | 0.00 | -- | -- | 0.00 | -16.76 | -21.91 | -17.52 | -23.04 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.73 | -- | -- | -- |
| Bellring Brands Inc | 1.84bn | 191.50m | 7.49bn | 420.00 | 39.92 | -- | 31.66 | 4.06 | 1.44 | 1.44 | 13.84 | -1.90 | 2.40 | 5.40 | 8.71 | 4,389,286.00 | 24.91 | 18.89 | 31.72 | -- | 32.74 | 32.44 | 10.39 | 10.10 | 1.84 | 5.07 | 1.42 | 0.00 | 21.53 | 15.03 | 101.09 | 13.80 | -18.48 | -- |
| Cerevel Therapeutics Holdings Inc | 0.00 | -460.47m | 7.67bn | 355.00 | -- | 13.57 | -- | -- | -2.72 | -2.72 | 0.00 | 3.10 | 0.00 | -- | -- | 0.00 | -44.76 | -- | -48.20 | -- | -- | -- | -- | -- | -- | -- | 0.3745 | -- | -- | -- | -23.14 | -- | -- | -- |
| Vaxcyte Inc | 0.00 | -436.82m | 8.11bn | 254.00 | -- | 4.09 | -- | -- | -4.22 | -4.22 | 0.00 | 18.24 | 0.00 | -- | -- | 0.00 | -28.19 | -34.22 | -29.52 | -37.21 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -80.00 | -- | 107.28 | -- |
| Legend Biotech Corp (ADR) | 342.80m | -465.95m | 8.22bn | 1.80k | -- | 7.07 | -- | 23.96 | -2.60 | -2.60 | 1.90 | 6.39 | 0.2297 | 9.52 | 203.86 | 190,443.30 | -31.22 | -37.71 | -37.33 | -47.19 | 52.35 | -- | -135.92 | -286.51 | 5.57 | -24.44 | 0.2233 | -- | 143.70 | 42.15 | -16.11 | -- | 1.57 | -- |
| Elanco Animal Health Inc | 4.37bn | -1.30bn | 8.49bn | 9.30k | -- | 1.40 | -- | 1.95 | -2.64 | -2.64 | 8.84 | 12.26 | 0.2931 | 1.21 | 4.28 | 469,354.80 | -8.74 | -3.27 | -9.65 | -3.65 | 55.28 | 54.28 | -29.83 | -11.53 | 1.96 | 0.853 | 0.4877 | -- | 0.136 | 7.57 | -1,478.21 | -- | 2.74 | -- |
Data as of May 17 2024. Currency figures normalised to Ascendis Pharma A/S's reporting currency: US Dollar USD
75.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RA Capital Management LPas of 31 Dec 2023 | 10.11m | 17.52% |
| Artisan Partners LPas of 31 Dec 2023 | 5.75m | 9.96% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 4.77m | 8.27% |
| Westfield Capital Management Co. LPas of 31 Mar 2024 | 4.08m | 7.06% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 3.99m | 6.91% |
| Janus Henderson Investors US LLCas of 31 Dec 2023 | 3.93m | 6.81% |
| Avoro Capital Advisor LLCas of 31 Dec 2023 | 3.76m | 6.51% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 3.25m | 5.63% |
| Capital Research & Management Co. (International Investors)as of 31 Dec 2023 | 2.18m | 3.78% |
| Massachusetts Financial Services Co.as of 31 Dec 2023 | 1.52m | 2.63% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
